Remdesivir | search
Click here to view Remdesivir news from 60+ newspapers.
Bookmark or Share- FDA Approves First Treatment for COVID-19 | FDAToday, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40...
- COVID-19 drugs: Are there any that work? - Mayo ClinicThe FDA has approved an antiviral drug called remdesivir (Veklury) to treat COVID-19 in adults and children who are age 12 and older. Remdesivir may be prescribed for people who are hospitalized with COVID-19 and need supplemental oxygen or have a higher risk of serious illness.
- Remdesivir - WikipediaRemdesivir has been authorized for emergency use in India, Singapore, and approved for use in Japan, the European Union, the United States, and Australia for people with severe symptoms. Remdesivir is the first treatment for COVID‑19 to be approved by the U.S. Food and Drug Administration (FDA).
- Remdesivir | COVID-19 Treatment GuidelinesLast Updated: February 29, 2024. Remdesivir is a nucleotide prodrug of an adenosine analog. It binds to the viral RNA-dependent RNA polymerase and inhibits viral replication by terminating RNA transcription prematurely. Remdesivir has demonstrated in vitro and in vivo activity against SARS-CoV-2. 1.
- Remdesivir for the Treatment of Covid-19 — Final ReportRemdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV), 5-8 was...
More
